These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1338 related items for PubMed ID: 12167681

  • 21. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial.
    Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM.
    J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):217-21. PubMed ID: 10896696
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of botulinum toxin A in upper limb function of hemiplegic patients.
    Rousseaux M, Kozlowski O, Froger J.
    J Neurol; 2002 Jan; 249(1):76-84. PubMed ID: 11954872
    [Abstract] [Full Text] [Related]

  • 23. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke.
    Pittock SJ, Moore AP, Hardiman O, Ehler E, Kovac M, Bojakowski J, Al Khawaja I, Brozman M, Kanovský P, Skorometz A, Slawek J, Reichel G, Stenner A, Timerbaeva S, Stelmasiak Z, Zifko UA, Bhakta B, Coxon E.
    Cerebrovasc Dis; 2003 Jan; 15(4):289-300. PubMed ID: 12686794
    [Abstract] [Full Text] [Related]

  • 24. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study.
    Simpson DM, Gracies JM, Yablon SA, Barbano R, Brashear A, BoNT/TZD Study Team.
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):380-5. PubMed ID: 18977811
    [Abstract] [Full Text] [Related]

  • 25. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study.
    Sun SF, Hsu CW, Sun HP, Hwang CW, Yang CL, Wang JL.
    Neurorehabil Neural Repair; 2010 Jan; 24(1):34-41. PubMed ID: 19729582
    [Abstract] [Full Text] [Related]

  • 26. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD, Vuadens P, van Wijck FM, Stark S, Johnson GR, Barnes MP.
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [Abstract] [Full Text] [Related]

  • 27. Accuracy of botulinum toxin type A injection into the forearm muscles of chronic stroke patients with spastic flexed wrist and clenched fist: manual needle placement evaluated using ultrasonography.
    Picelli A, Roncari L, Baldessarelli S, Berto G, Lobba D, Santamato A, Fiore P, Smania N.
    J Rehabil Med; 2014 Nov; 46(10):1042-5. PubMed ID: 25103251
    [Abstract] [Full Text] [Related]

  • 28. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J, Bogucki A, Reclawowicz D.
    Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke.
    Santamato A, Panza F, Intiso D, Baricich A, Picelli A, Smania N, Fortunato F, Seripa D, Fiore P, Ranieri M.
    J Neurol Sci; 2017 Jul 15; 378():182-186. PubMed ID: 28566161
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke? A double-blind randomized clinical trial.
    Marco E, Duarte E, Vila J, Tejero M, Guillen A, Boza R, Escalada F, Espadaler JM.
    J Rehabil Med; 2007 Jul 15; 39(6):440-7. PubMed ID: 17624477
    [Abstract] [Full Text] [Related]

  • 36. Effects of repeated abobotulinumtoxinA injections in upper limb spasticity.
    Gracies JM, O'Dell M, Vecchio M, Hedera P, Kocer S, Rudzinska-Bar M, Rubin B, Timerbaeva SL, Lusakowska A, Boyer FC, Grandoulier AS, Vilain C, Picaut P, International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group.
    Muscle Nerve; 2018 Feb 15; 57(2):245-254. PubMed ID: 28590525
    [Abstract] [Full Text] [Related]

  • 37. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.
    Sheean G.
    Drug Saf; 2006 Feb 15; 29(1):31-48. PubMed ID: 16454533
    [Abstract] [Full Text] [Related]

  • 38. Safety and efficacy of letibotulinumtoxinA(BOTULAX®) in treatment of post stroke upper limb spasticity: a randomized, double blind, multi-center, phase III clinical trial.
    Do KH, Chun MH, Paik NJ, Park YG, Lee SU, Kim MW, Kim DK.
    Clin Rehabil; 2017 Sep 15; 31(9):1179-1188. PubMed ID: 28118733
    [Abstract] [Full Text] [Related]

  • 39. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke.
    Bakheit AM, Thilmann AF, Ward AB, Poewe W, Wissel J, Muller J, Benecke R, Collin C, Muller F, Ward CD, Neumann C.
    Stroke; 2000 Oct 15; 31(10):2402-6. PubMed ID: 11022071
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 67.